Drug maker Schering AG said Monday that its third-quarter net profit rose by 29 percent, lifted by stronger sales of its birth control pill and treatments for multiple sclerosis and program to cut costs. The Berlin-based company earned Ђ160 million (US$192.2 million), or 85 euro cents a share (US$1.02), compared with Ђ124 million, or 64 euro cents a share, in the quarter ended Sept. 30. Analysts had expected the company to report a profit of Ђ136 million
Dear readers! Please observe community rules and respect each other. We do not practice censorship. However, all offensive comments will be deleted, and their posters will be blocked.
Many in Europe believe that the United States cannot be trusted after four years of Donald Trump's presidency